2008 - Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy

Alcorn, Joe
November 2008
ACP Journal Club;11/18/2008, Vol. 149 Issue 5, p9
Academic Journal
The article presents information on a study conducted to find out if rifaximin is effective and safe for the treatment of hepatic encephalopathy. Studies selected compared rifaximin with placebo, another antimicrobial agent, or a nonabsorbable disaccharide for treatment of hepatic encephalopathy. It was concluded that in patients with hepatic encephalopathy, rifaximin is as effective as other antibiotics and may be more effective than nonabsorbable disaccharides.


Related Articles

  • Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. Als-Nielsen, Bodil; Gluud, Lise L.; Gluud, Christian // BMJ: British Medical Journal (International Edition);5/1/2004, Vol. 328 Issue 7447, p1046 

    Objective To assess the effects of non-absorbable disaccharides (lactulose and lactitol) in patients with hepatic encephalopathy. Data sources Cochrane Hepato-Biliary Group controlled trials register, Cochrane Library, Medline, and Embase until March 2003; reference lists of relevant articles;...

  • Hyperion Therapeutics' Glycerol Phenylbutyrate Meets Primary Endpoint in Phase II Study in Episodic Hepatic Encephalopathy.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article informs that Hyperion Therapeutics Inc.'s phase II study of glycerol phenylbutyrate, an investigational drug for the treatment of episodic hepatic encephalopathy (HE) has met its primary endpoint. The results from the study showed that the proportion of patients experiencing at least...

  • Drug Treatment of Encephalopathy Associated with Fulminant Liver Failure. TissiĆ©res, P.; devictor, D. // CNS Drugs;1999, Vol. 11 Issue 5, p335 

    Hepatic encephalopathy is a complex neuropsychiatric syndrome that may complicate either chronic or acute liver failure. Hepatic encephalopathy associated with fulminant liver failure is characterised by the development of cerebral oedema and intracranial hypertension, and has a poor outcome in...

  • Treatment of hepatic encephalopathy. Shawcross, Debbie L.; Jalan, Rajiv // BMJ: British Medical Journal (International Edition);7/10/2004, Vol. 329 Issue 7457, p112 

    Presents a letter to the editor of the July 10, 2004 issue of the "British Medical Journal" regarding the treatment of hepatic encephalopathy.

  • Treatment of hepatic encephalopathy. Als-Nielsen, Bodil; Gluud, Lise L.; Gluud, Christian // BMJ: British Medical Journal (International Edition);7/10/2004, Vol. 329 Issue 7457, p112 

    Presents a response to a letter to the editor of the July 10, 2004 issue of the "British Medical Journal" regarding the treatment of hepatic encephalopathy.

  • Another option for patients with liver disease. Sharma, Umang // Journal of Family Practice;Sep2010, Vol. 59 Issue 9, pE1 

    The article focuses on a study on the effectiveness of rifaximin in treating and preventing hepatic encephalopathy, conducted by researcher N. M. Bass and colleagues. The study, based on randomized controlled trial (RCT), revealed that the use of rifaximin is more effective in preventing chronic...

  • Diagnosis and treatment of hepatic encephalopathy. Savlan, Ilona; Liakina, Valentina; Valantinas, Jonas // Acta Medica Lituanica;2013, Vol. 20 Issue 1, p1 

    Background. Hepatic encephalopathy (HE) is a neuropsychiatric complication of liver cirrhosis which symptoms may vary from imperceptible to severe ones. In recent years, there have been some changes of fundamental hepatic encephalopathy pathogenesis and treatment. The early HE on the stage of...

  • Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study. Arata, Shinju; Tanaka, Katsuaki; Takayama, Kazuhisa; Moriwaki, Yoshihiro; Suzuki, Noriyuki; Sugiyama, Mitsugi; Aoyagi, Kazuo // BMC Emergency Medicine;2010, Vol. 10, p10 

    Background: It is thought that a good survival rate of patients with acute liver failure can be achieved by establishing an artificial liver support system that reliably compensates liver function until the liver regenerates or a patient undergoes transplantation. We introduced a new artificial...

  • How many good antidepressant medications have we missed? Blier, Pierre // Journal of Psychiatry & Neuroscience;Jul2004, Vol. 29 Issue 4, p248 

    This article focuses on antidepressant medications. Once antidepressant medications have been demonstrated to be safe for human use, they generally have to prove superior to placebo in at least 2 randomized, double-blind, placebo-controlled studies to be approved by regulatory agencies. It is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics